Keeping in mind the anti-inflammatory and anti-DM properties of adiponectin, one could hypothesize that increased adiponectin levels serve to protect patients at high risk of the harmful actions of pro-inflammatory and DM agents. Here, ADIPOQ is linked to diabetes mellitus.